TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients-Reference-Cited by-同舟云学术

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Rakova Jana¹,Truxova Iva¹,Holicek Peter¹²,Salek Cyril³⁴,Hensler Michal¹^ORCID,Kasikova Lenka¹,Pasulka Josef¹,Holubova Monika⁵,Kovar Marek⁶^ORCID,Lysak Daniel⁷,Kline Justin P.⁸,Racil Zdenek³⁴,Galluzzi Lorenzo⁹¹⁰¹¹¹²¹³,Spisek Radek¹²,Fucikova Jitka¹²

Affiliation:

1. Sotio, Prague, Czech Republic

2. Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic

3. Institute of Hematology and Blood Transfusion, Prague, Czech Republic

4. Institute of Clinical and Experimental Hematology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

5. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Czech Republic

6. Laboratory of Tumor Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic

7. Department of Hematology and Oncology, University Hospital in Pilsen, Czech Republic

8. Department of Medicine, University of Chicago, Chicago, IL, USA

9. Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA

10. Sandra and Edward Meyer Cancer Center, New York, NY, USA

11. Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA

12. Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA

13. Université de Paris, Paris, France

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1889822

Reference49 articles.

1. The cancer–natural killer cell immunity cycle

2. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

3. Natural killer cell memory in infection, inflammation and cancer

4. Control of Metastasis by NK Cells

5. The role of NK cells and CD39 in the immunological control of tumor metastases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An improved approach to generate IL-15+/+/TGFβR2−/− iPSC-derived natural killer cells using TALEN;Cell Reports Methods;2024-09

2. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

3. Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML);Frontiers in Genetics;2024-08-14

4. Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study;Transplant Immunology;2024-08

5. Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies;Cancer Communications;2024-07-28